Wird geladen...
Neoadjuvant treatment for resectable pancreatic adenocarcinoma
Pancreatic adenocarcinoma is the fourth leading cause of cancer mortality in the United States in both men and women, with a 5-year survival rate of less than 5%. Surgical resection remains the only curative treatment, but most patients develop systemic recurrence within 2 years of surgery. Adjuvant...
Gespeichert in:
| Veröffentlicht in: | World J Clin Oncol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734931/ https://ncbi.nlm.nih.gov/pubmed/26862486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v7.i1.1 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|